On sweet undeniable feeling of power of international intellectual feudalism, bias, discrimination, censoring and theft
This is an unannounced editorial; despite we promised to give platform for our international editors I decided to write myself to answer the rhetoric question addressed by junior researchers and clinicians – does your journal has impact factor, to submit or not submit?
The advent of advanced hematological and oncological treatment modalities including radiation therapy (RT) has led to increased survival in patients with a range of malignancies. However, this increased curative and disease free survival rate has been offset by the development of late treatment related complications, such as secondary malignancies and cardiovascular disease. This would explain why childhood cancer survivors exhibit a long-term survival rate that is significantly lower than age and gender matched population controls. When compared to the general population, the lifespan of these patients may be reduced by up to 10 years
Atrial fibrillation (AF) is the most common sustained arrhythmia. In the last 20 years, it has become one of the most important public health problems and a significant cause of increasing healthcare expenditures. The prevalence of AF is also increasing due to the improved ability to suspect and diagnose AF in the setting of variety of chronic cardiac and non-cardiac diseases.
This is a first piece we open for debate and discussion. As every editor can comprehend from the title of this short introduction, this is about may be some journal editors have experienced or it may only be intrinsic for our journal.